Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.155 USD | +1.17% | +1.65% | -26.95% |
05-09 | BioXcel Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-09 | Transcript : BioXcel Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.95% | 79.94M | |
+7.52% | 111B | |
+11.31% | 106B | |
-12.18% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.92% | 16.81B | |
+38.60% | 12.54B | |
-24.44% | 8.09B |
- Stock Market
- Equities
- BTAI Stock
- News BioXcel Therapeutics, Inc.
- BioXcel Therapeutics Prices $25 Million Registered Direct Offering of Shares, Warrants